ESR2 and B-cell chronic lymphocytic leukemia: An alternative hypothesis to our observation in women with CLL may involve the aromatization of testosterone to estradiol, an efficient agonist for ERβ, which is the main ER expressed in lymphoid tissues also overexpressed in CLL [11, 15, 35].